Loss of Egr1, a human del5q gene, accelerates BCR-ABL driven chronic myelogenous leukemia.

Maifrede, Silvia; Magimaidas, Andrew; Sha, Xiaojin; Mukherjee, Kaushiki; Liebermann, Dan A; Hoffman, Barbara

Maifrede, Silvia; Magimaidas, Andrew; Sha, Xiaojin; Mukherjee, Kaushiki; Liebermann, Dan A; Hoffman, Barbara.

Afiliación

Maifrede S; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Magimaidas A; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Sha X; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Mukherjee K; Current address: Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.
Liebermann DA; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Hoffman B; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.

Oncotarget ; 8(41): 69281-69294, 2017 Sep 19.

Article en En | MEDLINE | ID: mdl-29050203

Palabras clave

Egr1; Leukemic stem cells; chronic myelogenous leukemia; stress response protein; tumor suppressor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google